CTRI/2021/04/032665已完成3 期
ow molecular weight heparin in treatment of moderately severe and severe acute pancreatitis; A randomized control trial.
SMS Medical Jaipur0 个研究点目标入组 140 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 140
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients of moderately severe or severe acute pancreatitis. Admitted within 24hours of onset of symptoms. willing to participate
排除标准
- •Chronic pancreatitis. Traumatic pancreatitis. Hypersensitivity to low molecular weight heparin, heparin, pork products, benzyl alcohol or other ingredients of enoxaparin preparation or radio contrast agent. Any contraindication for low molecular weight heparin. Pregnancy and lactation. Charlson Comorbidity Index 5 or more
研究者
相似试验
进行中（未招募）
1 期
Heparin in the treatment of fetal growth restrictioEUCTR2020-000315-76-PTCentro Hospitalar Universitário de Lisboa Central, EPE120
进行中（未招募）
1 期
ow molecular weight heparin in advanced non small cell lung cancer (NSCLC): a randomized open label phase III study evaluating the effect of enoxaparin (Clexane) on survival and symptom control in patients with stage IIIb and IV NSCLC undergoing a cisplatin based first line chemotherapy: the syringes trial - SYRINGESEUCTR2007-007696-16-BETOGA Thoracic Oncology Group Antwerp
进行中（未招募）
不适用
ow molecular weight heparin (Fragmin) in pregnant women with a history of uteroplacental insufficiency and thrombophilia, a randomized trial - FRUITWomen with a history of pre-eclampsia and babies small for gestational ageEUCTR2005-005850-30-ATMedical University Vienna262
进行中（未招募）
1 期
ow-molecular-weight heparin in constituted vascular intrauterine growth restriction.Intrauterine growth restriction (IUGR)MedDRA version: 20.0Level: LLTClassification code 10022819Term: Intrauterine growth retardationSystem Organ Class: 100000004868MedDRA version: 20.0Level: LLTClassification code 10048489Term: Intrauterine growth retardSystem Organ Class: 100000004868MedDRA version: 20.0Level: LLTClassification code 10048488Term: Growth intrauterine retardSystem Organ Class: 100000004868EUCTR2016-000424-25-FRCHU Saint-Etienne162
已完成
不适用
PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT)ISRCTN94385648Hamilton Health Sciences (Canada)3,650